Meiji Yasuda Asset Management Co Ltd. Takes $996,000 Position in HCA Healthcare, Inc. $HCA

Meiji Yasuda Asset Management Co Ltd. purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,555 shares of the company’s stock, valued at approximately $996,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. Sumitomo Life Insurance Co. increased its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after buying an additional 20 shares during the last quarter. MJP Associates Inc. ADV lifted its stake in shares of HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after purchasing an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC increased its position in HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares in the last quarter. Anchyra Partners LLC lifted its position in HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after buying an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd increased its position in shares of HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after acquiring an additional 22 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the subject of several recent research reports. Jefferies Financial Group set a $450.00 price target on HCA Healthcare in a report on Tuesday, July 14th. Robert W. Baird dropped their target price on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday, July 27th. JPMorgan Chase & Co. lowered their price objective on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research report on Thursday, August 20th. Stephens decreased their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Finally, Morgan Stanley cut their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $429.19 on Tuesday. The stock has a market capitalization of $92.92 billion, a price-to-earnings ratio of 14.37, a PEG ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The company’s 50-day simple moving average is $397.94 and its 200-day simple moving average is $443.28.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the previous year, the business earned $6.84 EPS. The business’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, research analysts forecast that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is 10.45%.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.